Hacı Arak

6PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|Feb 13, 2025
Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio for Survival in Colorectal Cancer Patients Undergoing Surgery.

Hacı Arak, Ercan Gumusburun, Mustafa Seyyar

|Jul 25, 2024
The effect of examining somatic alterations with NGS in patients with solid tumors, on patient management: A single-center experience in Turkey.

Hacı Arak, Bahtiyar Sahinoğlu, Tulay Kus

|Apr 29, 2024
Prognostic significance of 68 Ga-FAPI PET/CT in patients with bone metastases in various cancers.

Hacı Arak, Umut Elboga, Yusuf Burak Cayirli

|Apr 26, 2022
The predictive value of vitamin D follow-up and supplementation on recurrence in patients with colorectal cancer.

Tulay Kus, Elif Isbilen, Gokmen Aktas

Pageof 1

Frequent Collaborators

3 joint publications

Mustafa Seyyar

2 joint publications

Tulay Kus

2 joint publications

Nargiz Majidova

2 joint publications

Murad Guliyev